MBX Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

MBX Biosciences (Nasdaq: MBX) said CEO Kent Hawryluk and CMO Sam Azoulay will present at two upcoming investor conferences in late Feb–early Mar 2026.

Events: Oppenheimer 36th Annual Healthcare Life Sciences Conference (virtual) on Feb 25, 2026 at 11:20–11:50 a.m. ET, and TD Cowen 46th Annual Health Care Conference in Boston on Mar 2, 2026 at 9:10–9:40 a.m. ET. Live webcasts and replays will be available via the company's events page and archived for about 90 days.

CARMEL, Ind., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present at and participate in the following upcoming investor conferences:

36^th Oppenheimer Annual Healthcare Life Sciences Conference (Virtual)

Date: Wednesday, February 25, 2026
Format: Fireside chat and 1x1 meetings
Time: 11:20 a.m. – 11:50 a.m. ET

TD Cowen 46^th Annual Health Care Conference

Date: Monday, March 2, 2026
Format: Fireside chat and 1x1 meetings
Time: 9:10 a.m. – 9:40 a.m. ET
Location: Boston, Massachusetts

The live webcasts can be accessed in the events section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events. Access to the webcast replays will be available approximately two hours after the completion of the events and will be archived on the Company’s website for approximately 90 days.

About MBX Biosciences
MBX Biosciences is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP™ platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism (HP) preparing for Phase 3 development; an obesity portfolio that includes MBX 4291 in Phase 1 development, as well as multiple discovery and pre-clinical obesity candidates; and imapextide (MBX 1416) for the treatment of post-bariatric hypoglycemia (PBH) in Phase 2 development. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at www.mbxbio.com and follow it on LinkedIn.

Media Contact:
Cassidy McClain
Inizio Evoke Comms
cassidy.mcclain@inizioevoke.com   
(619) 694-6291

Investor Contact:
Jim DeNike
MBX Biosciences
jdenike@mbxbio.com

FAQ

When will MBX (Nasdaq: MBX) present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference?

MBX will present on Wednesday, February 25, 2026 at 11:20–11:50 a.m. ET. According to MBX Biosciences, the session is virtual with a fireside chat plus 1x1 meetings and a live webcast.

What are the details for MBX's presentation at the TD Cowen 46th Annual Health Care Conference (MBX)?

MBX will present on Monday, March 2, 2026 at 9:10–9:40 a.m. ET in Boston. According to MBX Biosciences, the appearance includes a fireside chat and 1x1 meetings with an on-site format.

How can investors watch MBX (MBX) live webcasts and replays for these conferences?

Live webcasts are accessible via the events section of MBX's investor website at the provided events URL. According to MBX Biosciences, replays appear about two hours after each event and remain archived for roughly 90 days.

Who from MBX (Nasdaq: MBX) will present at the investor conferences in Feb–Mar 2026?

Kent Hawryluk, President and CEO, and Sam Azoulay, M.D., Chief Medical Officer, will present at both events. According to MBX Biosciences, both will participate in fireside chats and 1x1 meetings.

Will MBX (MBX) offer one-on-one meetings at the Oppenheimer and TD Cowen conferences?

Yes, MBX will hold 1x1 meetings in addition to fireside chats at both conferences. According to MBX Biosciences, each event schedule includes dedicated 1x1 meeting slots alongside the presentations.

How long will MBX (Nasdaq: MBX) webcast replays be available after the conferences?

Webcast replays will be archived on MBX's website for approximately 90 days after each event. According to MBX Biosciences, replays become available about two hours following event completion.